Not finding it? Sign in to also search OpenAlex live.
-
POS0806 LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES2024 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments
X. Baraliakos, D. van der Heijde, Filip E Van den Bosch, M. Magrey, Walter P. Maksymowych, Tetsuya Tomita, +8 more
2citations -
POS1122 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND AN INADEQUATE RESPONSE TO BIOLOGIC DMARD THERAPY: ONE-YEAR RESULTS FROM A PHASE 3 STUDY2023 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Xenofon Baraliakos, D. van der Heijde, Joachim Sieper, Robert Davies Inman, H. Kameda, Y. LI, +5 more
1citations -
P1618DEVELOPMENT AND EXTERNAL VALIDATION OF A PREDICTION MODEL FOR ADVERSE OUTCOME FOLLOWING KIDNEY TRANSPLANTATION FROM OLDER DECEASED DONORS2020 Nephrology Dialysis Transplantation article Medicine Renal Transplantation Outcomes and Treatments Open access
Chava L. Ramspek, Mostafa El Moumni, Martin B. A. Heemskerk, Eelaha Wali, Nichon Esther Jansen, Andries J. Hoitsma, +3 more
0citations -
Mitigating Representation Bias Caused by Missing Pixels in Methane Plume Detection2026 Communications in computer and information science conference-paper Environmental Science Atmospheric and Environmental Gas Dynamics Open access
Julia Wąsala, Joannes D. Maasakkers, Ilse Aben, Rochelle Schneider, Holger H. Hoos, Mitra Baratchi
1citations -
P140 Predicting long-term trajectories of the North Star Ambulatory Assessment (NSAA) total score in Duchenne muscular dystrophy (DMD): an updated model2023 Neuromuscular Disorders conference-abstract Medicine Neurogenetic and Muscular Disorders Research
Francesco Muntoni A, J. Signorovitch, Natalie Goemans, Adnan Manzur, N. Done, Gautam Sajeev, +8 more
0citations -
Tolérance et efficacité à long terme du bimékizumab chez les patients atteints de spondylarthrite ankylosante active : résultats à 5 ans d’une étude de phase IIb et de son extension en ouvert
Maxime Dougados, Atul A. Deodhar, Victoria Navarro‐Compán, Denis Poddubnyy, L. S. Gensler, Sofía Ramiro, +7 more
0citations -
Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction2023 Orphanet Journal of Rare Diseases article Neuroscience Genetic Neurodegenerative Diseases Open access
Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, +3 more
8citations -
Evaluation of Machine Learning Model Performance in Diabetic Foot Ulcer: Retrospective Cohort Study2025 JMIR Medical Informatics article Medicine Diabetic Foot Ulcer Assessment and Management Open access
Veerle van Velze, Hendrico L Burger, Tim J. van der Steenhoven, Hani Alers, Lauren N. Goncalves, Daniël Eefting, +9 more
3citations -
Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium2020 PLoS Medicine article Immunology and Microbiology Biosimilars and Bioanalytical Methods Open access
Signe Hässler, Delphine Bachelet, Julianne Duhazé, Natacha Szely, Salima Hacein-Bey Abina, Orhan Aktaş, +54 more
59citations -
LB0001 EFFICACY AND SAFETY OF DEUCRAVACITINIB UP TO WEEK 16 FROM POETYK PsA-1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Désirée M F M van der Heijde, Philip J. Mease, Carle F. Paul, F. Behrens, Laure Gossec, Yuichiro Kaneko, +15 more
4citations -
Study protocol and pilot results of an observational cohort study evaluating effect of red blood cell transfusion on oxygenation and mitochondrial oxygen tension in critically ill patients with anaemia: the INsufficient Oxygenation in the Intensive Care Unit (INOX ICU-2) study
Meryem Baysan, M. Sesmu Arbous, Egbert Gezinus Mik, Nicole Petra Juffermans, Johanna G. van der Bom
12citations -
POS0788 BIMEKIZUMAB DEMONSTRATED SUSTAINED EFFICACY AND SAFETY ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM TWO PHASE 3 STUDIES AND THEIR OPEN-LABEL EXTENSION2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
X. Baraliakos, A. Deodhar, Désirée M F M van der Heijde, Filip E Van den Bosch, M. Magrey, Walter P. Maksymowych, +6 more
1citations -
Cost-effectiveness of a medication review intervention for general practitioners and their multimorbid older patients with polypharmacy2024 Socio-Economic Planning Sciences article Medicine Pharmaceutical Practices and Patient Outcomes Open access
Katharina Tabea Jungo, Paola Salari, Rahel Meier, Michael Bagattini, Marco René Spruit, Nicolas Rodondi, +2 more
8citations -
POS0900 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES OVER 2 YEARS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PHASE 3 STUDIES2025 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
Florian Proft, Désirée M F M van der Heijde, Sergio Schwartzman, Joerg Ermann, Alexander Marten, Ute Massow, +6 more
0citations -
Abstract PS10-07: Pathologic complete response and 3-year survival with or without pertuzumab using real-world data of stage II and III HER2-positive breast cancer
Anna van der Voort, Marte C. Liefaard, Mette van Ramshorst, Erik D. van Werkhoven, Astrid N. Scholten, Jelle Wesseling, +3 more
0citations